About
Stratus

Garðar leads R&D at Kvikna Medical, bringing nearly 30 years of specialized experience in clinical EEG. He began his career at Taugagreining hf, where he was instrumental in creating the Nervus clinical EEG system, before heading the NicoletOne EEG platform design at VIASYS Healthcare. In 2008, Garðar co-founded Kvikna Medical ehf and has served as Managing Director since its inception. A pioneer in cloud-based clinical EEG services, Garðar holds an MSc in Mathematics from the University of Iceland and continues to drive the technological evolution of neurodiagnostic software.

ASSOCIATE PROFESSOR OF MEDICINE, DIVISION OF CARDIOVASCULAR MEDICINE, DEPARTMENT OF MEDICINE, HARVARD MEDICAL SCHOOL, BETH ISRAEL DEACONESS MEDICAL CENTER

DIRECTOR OF CARDIOLOGY GRAND ROUNDS, BETH ISRAEL DEACONESS MEDICAL CENTER

UNIVERSITY OF VIRGINIA, PH.D.

Dr. Verrier has investigated sudden cardiac death for more than three decades, having published over 300 original articles. He is inventor of 12 licensed patents for diagnosis and treatment of heart rhythm abnormalities and prediction of sudden cardiac death. During the past six years, he has focused attention on the cardiac effects of epilepsy in close collaboration with Professor Steven Schachter, a pioneer in VNS therapy and past president of AES. Their joint publications in Epilepsia and Epilepsy & Behavior have broken new ground in the study of patients with epilepsy.

PROFESSOR, DEPARTMENT CHAIR OF PSYCHOLOGY, COLORADO STATE UNIVERSITY

COLORADO STATE UNIVERSITY, PH.D.

Since 2013, Dr. Rojas has served as a faculty member in the Department of Psychology at Colorado State University. The primary theme of his work has been the identification of heritable biomarkers in autism, using non-invasive neuroimaging and electrophysiological techniques in first-degree relatives. His specialties include magnetoencephalography, electroencephalography, functional magnetic resonance imaging, autism, and schizophrenia.

ASSISTANT PROFESSOR OF NEUROLOGY, HARVARD MEDICAL SCHOOL

DIRECTOR OF CLINICAL NEUROPHYSIOLOGY AND ADULT EPILEPSY FELLOWSHIP, BETH ISRAEL DEACONESS MEDICAL CENTER

MICHAEL G. DEGROOTE SCHOOL OF MEDICINE, MD

Dr. Pang is an Assistant Professor of Neurology at Harvard Medical School and Director of the Clinical Neurophysiology and Adult Epilepsy Fellowship at Beth Israel Deaconess Medical Center. She is also Director of the comprehensive Women’s Health in Epilepsy Program, a collaborative effort across Boston medical institutions to address the special needs of women with epilepsy. Dr. Pang earned her medical degree at Michael G. DeGroote School of Medicine and specializes in the investigation and treatment of epilepsy and status epilepticus. Her clinical research includes work on T-wave alternans in patients with established or new onset epilepsy and the effects of anti-epileptic drugs and seizures on markers of sudden death in patients with epilepsy. She has published more than 20 peer-reviewed clinical papers related to epilepsy in renowned publications such as Experimental Neurology, Clinical Neurophysiology, and Seizure: European Journal of Epilepsy.

PROFESSOR, NEUROLOGY, UNIVERSITY OF CALIFORNIA SAN FRANCISCO

MEDICAL DIRECTOR, UCSF SEIZURE DISORDERS SURGERY PROGRAM

LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE NEW ORLEANS, MD

Dr. Knowlton’s research focuses on discovering advances in clinical neurophysiology and brain imaging that can affect decision-making in treatment of seizure disorders and brain tumors. The main focus of his work is to determine which advanced imaging discoveries should be moved to clinical application. He has worked specifically to improve and validate the clinical utilization of multiple modalities of brain imaging, including high-resolution magnetic resonance imaging (MRI), MR spectroscopy/spectroscopic imaging (MRS/MRSI), positron emission tomography (PET), magnetic and electrical source imaging (MSI/ESI), and ictal single photon emission computed tomography (SPECT). From the very beginning of his career, Dr. Knowlton has taken advantage of combining multiple imaging modalities to allow comparison of the relative merits for each test to determine if novel information can be discerned and measure whether purported advances improve patient care.

DIRECTOR, MID-ATLANTIC EPILEPSY AND SLEEP CENTER

CLINICAL PROFESSOR, NEUROLOGY, GEORGE WASHINGTON UNIVERSITY

CAMBRIDGE UNIVERSITY, MD

Dr. Klein’s clinical research includes novel treatments of epilepsy, dietary treatments of epilepsy in adults, prevention of epilepsy after traumatic brain injury, the effect of sex and stress hormones on epilepsy, and women with epilepsy.

He has received grants from the National Institutes of Health and the American Epilepsy Society, and investigator-initiated study grants from several pharmaceutical companies. Dr. Klein has published more than 45 peer-reviewed articles and contributed chapters to several books on epilepsy. He has been a member of the American Epilepsy Society Scientific Program Committee, Treatment Committee, and the Health Reform Task Force. Currently, he acts as a reviewer for a number of neurological, epilepsy and endocrinological journals and is chair of the AES Corporate Advisory Council. He is the Co-Founder and Co-Chair of the North American Consortium of Private Epilepsy Practices.

Omotola Hope, MD, is a board-certified neurologist who specializes in treating epilepsy and other types of seizures. Hope is a graduate of the University of Pennsylvania School of Medicine. She completed an internship in internal medicine at North Shore University Hospital in Manhasset, N.Y., and her residency in neurology at Yale New Haven Hospital in Connecticut. She also completed a fellowship in epilepsy at Yale New Haven Hospital, as well as a research fellowship through the Robert Wood Johnson Clinical Scholars Program at Yale University School of Medicine. She currently treats patients at Houston Methodist Sugar Land and was previously at Memorial Hermann Hospital, where she also served as an associate professor of neurology and program director of the epilepsy fellowship at McGovern Medicine School at the University of Texas Health Science Center – Houston.

MEDICAL DIRECTOR, BIOGEN

TUFTS UNIVERSITY SCHOOL OF MEDICINE, MD

Dr. Cochrane completed his residency in neurology in the Partners Neurology Program at Massachusetts General Hospital and Brigham and Women’s Hospital (BWH). He then finished a fellowship in neuromuscular medicine and electromyography at BWH. He completed the Fellowship in Medical Ethics at Harvard Medical School, and then served as a faculty fellow at the Safra Foundation Center for Ethics at Harvard University. Since 2005, he has worked as an attending neurologist specializing in neuromuscular disease at BWH. He also worked as senior ethics consultant at BWH and served on the Partners IRB. He taught medical ethics to Harvard Medical students, residents, faculty, and nursing staff at all levels, and was the first director of neuroethics at the Center for Bioethics at Harvard Medical School. In 2018, Dr. Cochrane joined Biogen as the medical director.

DIRECTOR, UNIVERSITY OF SOUTH FLORIDA/TAMPA GENERAL HOSPITAL COMPREHENSIVE EPILEPSY PROGRAM

PROFESSOR, NEUROLOGY AT USF

Selim Benbadis, MD, is a board-certified epileptologist and clinical neurophysiologist. Benbadis graduated from medical school at the University of Nice (Nice, France), where he completed a residency in family medicine. He completed his neurology residency at the Cleveland Clinic Foundation where he stayed an additional 2 years to complete a fellowship in epilepsy, EEG, and sleep medicine. Dr. Benbadis is currently a professor of neurology at the University of South Florida and the Director of the University of South Florida /Tampa General Hospital Comprehensive Epilepsy Program. His interests are in the diagnosis and management of seizures that are difficult to control and the misdiagnosis of epilepsy. He has authored more than two hundred articles and book chapters. He also has a strong interest in medical writing and editing and serves on several editorial boards. Finally, he has a strong interest in education, serves as faculty on numerous courses each year, and has received several teaching awards.

CHIEF MEDICAL OFFICER, CENTER FOR MENTAL HEALTH

CLINICAL PROFESSOR, NEUROLOGY & PSYCHIATRY, UNIVERSITY OF COLORADO SCHOOL OF MEDICINE

CLINICAL PROFESSOR, PSYCHIATRY, NEUROLOGY, PHYSICAL MEDICINE & REHABILITATION, BAYLOR COLLEGE OF MEDICINE

SENIOR SCIENTIST, BRAIN INJURY RESEARCH CENTER AT TIRR MEMORIAL HERMANN

UNIVERSITY OF MICHIGAN MEDICAL SCHOOL, MD

Over the last 20 years, Dr. Arciniegas’ clinical work and patient-oriented research as a subspecialist in behavioral neurology and neuropsychiatry has focused on the phenomenology, neurobiology, and rehabilitation of the cognitive and noncognitive neuropsychiatric sequelae of traumatic brain injury (TBI), other acquired brain injuries and neurodegenerative disorders, and neurodevelopmental conditions, including schizophrenia spectrum and other psychotic disorders. He has authored more than 115 peer-reviewed journal articles, over 130 peer-reviewed abstracts, nearly three-dozen book chapters, and more than 40 additional media-related works for professional and lay audiences. He is editor of the Journal of Neuropsychiatry and Clinical Neurosciences and a member of multiple editorial and scientific review boards in the clinical neurosciences. In addition to his administrative, clinical, and academic duties, Dr. Arciniegas serves as chairman and CEO of the International Brain Injury Association, is President-elect of the International Neuropsychiatric Association, and contributes his efforts to governmental and nongovernmental organizations striving to improve the lives of persons and families affected by brain injuries

Mike leads the Financial Planning & Analysis, Revenue Cycle, and Managed Care teams at Stratus. Since 2016, he has been instrumental in aligning business functions and strengthening the organization’s financial health through data-driven decision-making. With over 15 years of leadership experience, including progressive roles at CIT Group, Mike excels in financial modeling and strategic planning. He earned his MBA from California State University, Monterey Bay, and a BBA from Texas State University. Mike is committed to fostering a culture of accountability and innovation to support Stratus’ best-in-class neurodiagnostic mission.

David oversees the Corporate Compliance Program at Stratus, ensuring the organization navigates the complex regulatory landscape with a culture of ethics. An attorney with extensive federal and state trial experience, David has spent more than 20 years at the intersection of law and healthcare. He previously served as General Counsel for PDS Heart (acquired by BioTel) and was the founding Chief Compliance Officer at Watermark Medical, where he helped pioneer the home sleep testing market. His expertise includes managing large-scale acquisitions and scaling diagnostic service providers into national leaders. David received his B.S. from the University of Maryland and his J. D. from the University of Baltimore School of Law.

Jennifer joined Stratus in 2019 to lead global marketing solutions that drive sales and strategic growth. With several decades of experience at industry giants like Johnson & Johnson and St. Jude Medical (Abbott), she is an expert in identifying market drivers and developing unique value propositions. Jennifer’s career is defined by her ability to build collaborative, cross-functional relationships that bridge the gap between clinical value and commercial success. She has held additional leadership roles at MedAssets (Vizient) and Texas Health Resources, consistently delivering high-impact results across diverse customer segments and healthcare channels. Jennifer received her MBA from Southern Methodist University's Cox School of Business and completed her B.A. at the University of Missouri-Columbia.

Felicia directs enterprise-wide people strategies to drive workforce engagement and scalable growth at Stratus. With over 25 years of HR leadership, she specializes in building optimized infrastructures that improve retention and streamline compliance. Felicia holds a BS from the University of North Texas and an MS in Human Resources and Business from Amberton University. She is a dedicated advocate for inclusive leadership, serving as a member of the Texas Diversity Council, DallasHR, and SHRM. An alumna of North Texas LEAD, Felicia is committed to fostering a high-performance culture rooted in equity.

Caleb oversees clinical field teams and pre/post-service operations, including patient scheduling and reporting. Since joining Stratus in 2016, he has risen from Business Development Analyst to a key operational leader, focusing on the efficient movement of capital and human resources. Caleb specializes in process optimization through AI and workflow automation to deliver exceptional EEG services. Before his decade in healthcare, Caleb was an educator and also played in the Philadelphia Phillies MiLB system. Caleb holds a BBA in Economics from the University of Louisiana-Monroe and is dedicated to driving scalable, technology-driven operational solutions.

Lane leads Stratus’ commercial strategy, guiding growth initiatives to meet the evolving needs of the healthcare market. He brings a wealth of experience from the Fortune 500 sector, having recently served as VP of Business Development for Tenet Healthcare, the second-largest investor-owned hospital company in North America. Lane also held leadership roles at Health Management Associates, overseeing 70 hospitals, and spent nine years in various leadership positions at Novartis Pharmaceuticals. A graduate of the University of Alabama, Lane specializes in integrating business development with long-term organizational scaling.

Patti is a seasoned financial leader and CPA with more than 25 years of experience in the healthcare sector. Before joining Stratus, she served as CFO of HealthTrackRx and Med Fusion Clinical Laboratory, overseeing financial strategies for organizations focused on clinical trials and cancer care. Her previous tenure at Ameripath included serving as VP of Finance and Billing for the Hospital Division, where she managed 28 practices servicing 380 hospitals nationwide. With a career marked by successful acquisitions by Quest Diagnostics, Patti is an expert in scaling financial operations for market-leading providers. She holds a degree in Accounting from Bradley University.

Dr. Slater joined Stratus in 2018, bringing over 30 years of expertise in epilepsy and clinical neurophysiology. He leads Stratus' AI division, where he pioneers the use of AI and machine learning to identify neurological biomarkers. Previously, Dr. Slater directed the Texas Comprehensive Epilepsy Program, transforming it into one of the nation’s largest surgical hubs. A prolific researcher, he has authored 80+ publications with over 2,400 citations. He is a Fellow of the American Epilepsy Society, the American Clinical Neurophysiology Society, and the American Academy of Neurology. Dr. Slater earned his MD from the University of Pittsburgh and completed his residency and fellowship at the University of Miami.

Charlie is an accomplished healthcare innovator with over 30 years of leadership experience driving operational excellence across the health-tech landscape. Prior to joining Stratus, he served as CEO of DCI Health Technology Inc. (a Foxconn company), where he delivered digital solutions to enhance patient safety and global health system efficiency. His extensive background includes serving as SVP of Sales and Marketing at Sotera Wireless and co-founding Watermark Medical, a leader in sleep diagnostics. Earlier in his career, Charlie held executive roles at BioTel/Philips and PSS/World Medical (McKesson). A graduate of Florida State University, Charlie is dedicated to transforming the care continuum through high-impact innovation and improved patient outcomes.